GlobalRPH - Neurology/Neuroscience News

Medical News

< back to feeds
Neurology/Neuroscience News
Metabolic Effects Significantly Lower With INVEGA(R) Compared To Olanzapine New data from a 6-month open label randomised controlled trial show INVEGA® (paliperidone ER) is associated with significantly less metabolic effects compared to oral olanzapine in people with schizophrenia, while demonstrating comparable efficacy.1 The results were presented at the 15th Biennial Winter Workshop in Psychoses in Barcelona, Spain. ...more	20 Nov 2009
Economics, Neuroscience And Hormones Workshop A workshop on "Neuroeconomics and Endocrinological Economics," being held Nov. 20 and 21 at UC Davis, will be the first to bring together experts in neuroscience, economics and hormone physiology in one event, according to organizers. Neuroeconomics has emerged as a new field in recent years, as both economists and neuroscientists have used brain scanning technology such as functional magnetic resonance imaging to investigate how people make decisions. ...more	20 Nov 2009
Surgery Not Linked To Memory Problems In Older Patients For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions. In fact, the researchers were not able to detect any long-term cognitive declines attributable to surgery in a group of 575 patients they studied. ...more	20 Nov 2009
Study Examines Challenges Of Diagnosing Neurofibromatosis Type 1-like Syndrome An analysis of patients with a syndrome similar to the genetic disorder, neurofibromatosis type 1, indicates that diagnosis may be difficult because of shared clinical findings, such as certain pigmentary characteristics, according to a study in the November 18 issue of JAMA. ...more	20 Nov 2009
Residential Design For Persons With Neurological Disability IOS Press announces the November 2009 publication of a special issue of NeuroRehabilitation: An International Journal devoted to residential design for persons with neurodisability. ...more	20 Nov 2009
Paralysis In Animals Triggered By New On-Off 'Switch' - Reversed With A Beam Of Light In an advance with overtones of Star Trek phasers and other sci-fi ray guns, scientists in Canada are reporting development of an internal on-off "switch" that paralyzes animals when exposed to a beam of ultraviolet light. The animals stay paralyzed even when the light is turned off. When exposed to ordinary light, the animals become unparalyzed and wake up. Their study appears in the Journal of the American Chemical Society (JACS). ...more	20 Nov 2009
Grants From Michael J. Fox Foundation Awarded To BIDMC Scientists For Parkinson's Research Beth Israel Deaconess Medical Center (BIDMC) neurologists Alvaro Pascual-Leone, MD, PhD, and Daniel Tarsy, MD, have been awarded grants totaling more than $1.5 million from the Michael J. Fox Foundation for Parkinson's Research (MJFF) to conduct investigations aimed at improving the quality of life for patients with Parkinson's disease. ...more	20 Nov 2009
Drug Studied As Possible Treatment For Spinal Injuries Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed. The chemical compound also might be developed as a treatment for multiple sclerosis. ...more	20 Nov 2009
Spineology Receives FDA Clearance For Capture™ Facet Screw System Spineology Inc., developer and manufacturer of minimally invasive spinal surgery devices, announced today that it has received FDA clearance for its minimally invasive surgery (MIS) Capture™ Facet Screw System. The Capture System was developed by Spineology in mid-2009 under the direction of Dr. Chet Sutterlin, product development consultant. ...more	20 Nov 2009
FDA Approves New Drug For Pain That Persists After Shingles The US Food and Drug Administration (FDA) announced yesterday that it has approved Qutenza (capsaicin) 8% patch for the treatment of post-herpetic neuralgia (PHN), an often excruciating pain that can persist for weeks, months and even years in 10 to 15 per cent of people who get shingles. The medicated skin patch, which is made by Lohmann Therapie-Systems AD of Andernach, Germany and distributed in the US by NeurogesX Inc. ...more	19 Nov 2009
Structural Changes In Brain May Help Offset Loss Of Vision And Strengthen Other Senses Visually impaired people appear to be fearless, navigating busy sidewalks and crosswalks, safely finding their way using nothing more than a cane as a guide. The reason they can do this, researchers suggest, is that in at least some circumstances, blindness can heighten other senses, helping individuals adapt. ...more	19 Nov 2009
The Protein Srebp2 Drives Cholesterol Formation In Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases Prions are causing fatal and infectious diseases of the nervous system, such as the mad cow disease (BSE), scrapie in sheep or Creutzfeldt-Jakob disease in humans. Scientists of Helmholtz Zentrum MÃ¼nchen and Technische UniversitÃ¤t MÃ¼nchen have now succeeded in elucidating another disease mechanism of prion diseases: The prion-infected cell changes its gene expression and produces increased quantities of cholesterol. Prions need this for their propagation. ...more	19 Nov 2009
Findings That Should Speed The Development Of Drugs For Parkinson's Disease Australian scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's Disease. People with Parkinson's Disease suffer from muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. These primary symptoms are caused by the loss of dopamine producing nerve cells in the brain. ...more	19 Nov 2009
Stanford/Packard Study In Mice Suggests New Down Syndrome Treatment At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. ...more	19 Nov 2009
Scientific Link To Autism Identified During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery. The Center examined the neuroscientific dynamics of logic and emotion in decision making while researching neuroscience in business. They found unique corollary relationships between various brain chemicals (neurohormones, neurotransmitters, etc.). ...more	19 Nov 2009
Good News On Multiple Sclerosis And Pregnancy There is good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. A new study shows that pregnant women with multiple sclerosis are only slightly more likely to have cesarean deliveries and babies with a poor prenatal growth rate than women who do not have MS. ...more	19 Nov 2009
Cognitive Dysfunction Reversed In Mouse Model Of Down's Syndrome A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. ...more	19 Nov 2009
Collaboration With University Of Washington Aims To Prevent Dementia, Including Alzheimer's Every two years, 2,000 senior Group Health patients check in with the Adult Changes in Thought (ACT) study. The joint project between Group Health Research Institute and the University of Washington (UW) focuses on finding ways to delay or prevent dementia, including Alzheimer's disease, and declines in memory and thinking. It aims to deepen understanding of how the body - especially the brain - ages. ...more	19 Nov 2009
NIH Awards $8.5 Million For Research On Pharmaceuticals For Children Studying drugs in pediatric populations is challenging because drugs often affect children differently than they do adults. The scarcity of pediatric studies limits the ability of doctors and scientists to predict drug dosing, safety and efficacy in children. To address this gap, the National Institutes of Health has announced 18 grants to help determine outcome measures and increase the likelihood of success of future trials of treatments for children. ...more	19 Nov 2009
Are Teenagers Wired Differently Than Adults? Parents have long suspected that the brains of their teenagers function differently than those of adults. With the advent of magnetic resonance imaging, or MRI, we have begun to appreciate how the brain continues to develop structurally through adolescence and on into adulthood. High emotionality is a characteristic of adolescents and researchers are trying to understand how 'emotional areas' of the brain differ between adults and adolescents. ...more	19 Nov 2009
Pages of Results: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]
Neurology/Neuroscience News courtesy of Medical News Today	back to top

Medical News

Looking for a Job?

Career Center

Popular Tools

Disclaimer Contact Us Privacy Policy Website Search	We comply with the HONcode standard for health trustworthy information: Verify here. Copyright © 2007 GlobalRPh Inc.